Product Dossier
ADDAVEN
Product Dossier for ADDAVEN (chromic chloride hexahydrate, Fresenius Kabi). ARTG record, PBS listing, PBAC outcomes, AusPAR — compiled by arcimedes.
- Sponsor: Fresenius Kabi
- Active ingredient: chromic chloride hexahydrate
- Therapeutic area: Other
- Same area: OTODEX
- Same area: APO-CLONIDINE
What it is
ADDAVEN is a concentrated injection supplied in ampoule form, sponsored by Fresenius Kabi.
Approved indications
— To meet basal to moderately increased requirements of trace elements in parenteral nutrition in adults, when either oral or enteral nutrition is inappropriate.
Regulatory history
ADDAVEN was first listed on the ARTG on 29 July 2016. TGA approval was granted on 26 July 2016.